PLUS1
0.455
-0.0374 (-7.6%)
-0.0374 (-7.6%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 2,540,449 |
|
|||||
| News | - | ||||||
| Day High | 0.49 | Low High |
|||||
| Day Low | 0.4501 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Athenex Inc | ATNX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0374 | -7.6% | 0.455 | 19:59:22 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.49 | 0.4501 | 0.49 | 0.4566 | 0.4924 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,522 | 2,540,449 | $ 0.4692713 | $ 1,192,160 | - | 0.4051 - 3.91 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:39 | formt | 5,000 | $ 0.455 | USD |
Period:
Draw Mode:
Athenex Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 55.33M | 121.61M | 99.73M | $ 120.18M | $ - | -1.92 | -0.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1.28M | 6.00% |
Athenex News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATNX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.55 | 0.565 | 0.4501 | 0.5162311 | 3,279,113 | -0.095 | -17.27% |
| 1 Month | 0.677 | 1.19 | 0.4501 | 0.6965239 | 3,736,675 | -0.222 | -32.79% |
| 3 Months | 0.494 | 1.19 | 0.4051 | 0.6196406 | 2,163,595 | -0.039 | -7.89% |
| 6 Months | 0.80 | 1.20 | 0.4051 | 0.6573314 | 1,458,274 | -0.345 | -43.13% |
| 1 Year | 3.26 | 3.91 | 0.4051 | 1.37 | 1,273,938 | -2.81 | -86.04% |
| 3 Years | 15.71 | 22.00 | 0.4051 | 5.80 | 1,516,475 | -15.26 | -97.1% |
| 5 Years | 15.31 | 22.00 | 0.4051 | 7.11 | 1,056,146 | -14.86 | -97.03% |
Athenex Description
| Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer. Its current clinical pipeline is derived from Orascovery, based on a P-glycoprotein (P-gp) pump inhibitor, Src Kinase inhibition, T-cell receptor-engineered T-cells, and arginine deprivation therapy technology platforms. It is primarily engaged in conducting research and development activities through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting preclinical and clinical testing, recruiting personnel, identifying and evaluating additional drug candidates for potential in-licensing or acquisition, and raising capital to support development and commercialization activities. |
